Background: Currently, there is little knowledge concerning expression of metallothionein-III (MT-III), also known as growth-inhibitory factor, in non-small cell lung cancer (NSCLC).

Materials And Methods: In this study, we evaluated MT-III expression in 184 patients using immunohistochemistry and in 61 cases using real-time polymerase chain reaction.

Results: MT-III mRNA expression was significantly higher in NSCLC as compared to non-malignant lung tissues (NMLT; p<0.0086). MT-III expression was noted in the cytoplasm and nucleus of cancer cells. Significantly lower nuclear MT-III (p<0.0001) expression and significantly higher cytoplasmic MT-III (p=0.0068) expression was noted in the pneumocytes of NMLT, as compared to NSCLC. Nuclear MT-III expression was significantly higher in G1 cases as compared to G2 (p=0.0308) and G3 (p=0.0194) cases. Low cytoplasmic MT-III expression was associated with larger primary tumour size (p=0.0378). Lower MT-III mRNA and cytoplasmic MT-III expression was associated with poor patient outcome (p=0.0410 and p=0.0347, respectively).

Conclusion: MT-III expression may have an impact on the pathogenesis of NSCLC.

Download full-text PDF

Source

Publication Analysis

Top Keywords

expression metallothionein-iii
8
non-small cell
8
cell lung
8
lung cancer
8
expression
4
metallothionein-iii patients
4
patients non-small
4
cancer background
4
background currently
4
currently knowledge
4

Similar Publications

Article Synopsis
  • Oxidative stress contributes to various diseases, including neurodegenerative conditions like Alzheimer's, where reactive oxygen species (ROS) disrupt protein function.
  • Metallothionein-3 (MT3), a metalloprotein abundant in the brain, is shown to play a crucial role in managing oxidative stress, especially when it binds with metals like zinc or cadmium.
  • The study presents findings that indicate MT3 oxidizes more rapidly than its kidney counterpart (MT1), with distinct oxidation pathways that suggest a protective role for zinc in its fully metalated form.
View Article and Find Full Text PDF

mG-modified mt-tRF3b-LeuTAA regulates mitophagy and metabolic reprogramming via SUMOylation of SIRT3 in chondrocytes.

Biomaterials

March 2025

Department of Sports Medicine, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China. Electronic address:

N7-methylguanosine (mG) modification is one of the most prevalent RNA modifications, and methyltransferase-like protein-1 (METTL1) is a key component of the mG methyltransferase complex. METTL1-catalyzed mG as a new RNA modification pathway that regulates RNA structure, biogenesis, and cell migration. Increasing evidence indicates that mG modification has been implicated in the pathophysiological process of osteoarthritis (OA).

View Article and Find Full Text PDF

A Novel Manganese Ion Delivery Carrier Promotes Immune Cell Proliferation and Enhances Innate Immune Responses.

ACS Omega

September 2024

Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.

Manganese is a transition metal that is an essential trace element for human health. Manganese ions (Mn), which serve as one of the most common transition metal ions, play vital roles in enhancing innate immune responses. However, immune agonists based on Mn are poorly utilized in clinical trials due to poor chemodynamics and adverse events.

View Article and Find Full Text PDF

Objectives: Previous studies have shown that gene expressions can be regulated in the hippocampus of rats after seizures induced by kainic acid (KA). The aim of this study was to examine the potential regulatory impact of KA administration on gene expression levels of enzymes responsible for drug metabolism in rat hippocampal tissue.

Materials And Methods: Rats received intraperitoneal injections of KA and saline at a dose of 10 mg/kg.

View Article and Find Full Text PDF

Unique expression and critical role of metallothionein 3 in the control of osteoclastogenesis and osteoporosis.

Exp Mol Med

August 2024

Department of Cell and Developmental Biology, School of Dentistry, Seoul National University, Seoul, 03080, Republic of Korea.

Bone homeostasis is maintained by an intricate balance between osteoclasts and osteoblasts, which becomes disturbed in osteoporosis. Metallothioneins (MTs) are major contributors in cellular zinc regulation. However, the role of MTs in bone cell regulation has remained unexplored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!